Asset
ABT-072
Abbott Laboratories Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (5)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT00890318 | phase1 | completed | 2009-04-01 | 2009-07-01 | Abbott | A Study in Healthy Adult Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetic Profiles of Multiple Doses of ABT-072 Used to Treat Hepatitis C |
| NCT00752687 | phase1 | completed | 2008-09-01 | 2009-05-01 | Abbott | A Study of ABT-072 in Healthy and Hepatitis C Virus Genotype 1-Infected Adults |
| NCT01081483 | phase1 | completed | 2010-03-01 | 2010-06-01 | Abbott | A Study of Single Doses of ABT-072 in Japanese Healthy Male Adults |
| NCT00947440 | phase1 | completed | 2009-07-01 | 2009-08-01 | Abbott | Evaluation of the Bioavailability of Two ABT-072 Tablet Formulations as Compared to ABT-072 Capsule Formulation |
| NCT00982826 | phase1 | completed | 2009-09-01 | 2009-12-01 | Abbott | Single and Multiple Dose Evaluation of ABT-072 and to Evaluate the Effect of Food on the Pharmacokinetics of ABT-072 |
FDA applications (0)
This company has no applications containing this asset.